HomeCategoryNewsFrance: Transgene reaffirms financial visibility with sale of stake in Chinese company
ArticlesNews

France: Transgene reaffirms financial visibility with sale of stake in Chinese company

By Nick Herbert
-

Euronext Paris-listed Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, has sold its minority stake in a Chinese biopharmaceutical company to receive US$15.3m….

Subscription required

This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?
Previous article
Russia: Essity sells Russian market operations to New Technologies
Next article
Denmark: DanCann Pharma receives first tranche of convertible loan
Nick Herbert
Nick Herbert
Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications. For the last five years he has been covering global capital markets, ESG finance and healthcare markets on a freelance basis.
Related Articles
More From Author

…

Subscription required

This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?

…

Subscription required

This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?
Advertisement

Related Resources

Related Events